Innovations In Clinical Neuroscience

ISCTM Supplement 2015

A peer-reviewed, evidence-based journal for clinicians in the field of neuroscience

Issue link: http://innovationscns.epubxp.com/i/499434

Contents of this Issue

Navigation

Page 40 of 41

VOLUME 12 • NUMBER 3–4 MARCH–APRIL 2015 • SUPPLEMENT A A SUPPLEMENT TO INNOVATIONS IN CLINICAL NEUROSCIENCE ISCTM wishes to recognize its Sustaining Corporate Members PLATINUM Janssen, Pfizer GOLD Bracket, Roche, Shire SILVER AbbVie, Lilly, Otsuka, Sunovion, Takeda BRONZE Alkermes, AMGEN, Boehringer-Ingelheim, Covance, Forum, INC Research, NeuroCog Trials, Novartis, PPD, ProPhase, Thievon-Wright Consulting [ V O L U M E 1 2 , N U M B E R 3 – 4 , S U P P L E M E N T A , M A R C H – A P R I L 2 0 1 5 ] Innovations in CLINICAL NEUROSCIENCE 41S BECOME A MEMBER Not a Member Yet? Some of the member benefits you could be receiving: discounted registration fees, access to the full library of archived meeting materials, and participation in ISCTM Working Groups. click here to JOIN TODAY ISCTM Workgroups ISCTM supported Working Groups provide an outlet for broader membership participation in the ongoing work of the Society. Below is listing of active ISCTM working groups. For detailed information on each working group or information on joining or forming an ISCTM working group CLICK HERE. ADAPTIVE DESIGN Chairs: Ron Marcus, MD, and Judith Kando, PharmD ADDRESSING METHODOLOGICAL CHALLENGES IN INTERNATIONAL CNS CLINICAL TRIALS Chairs: Richard Keefe, PhD, and Amir Kalali, MD ALGORITHMS/FLAGS TO IDENTIFY CLINICAL INCONSISTENCY IN THE USE OF RATING SCALES IN CNS RCTs Chairs: Jonathan Rabinowitz, MD, and Nina R. Schooler, PhD ASSESSING ABUSE LIABILITY POTENTIAL Chairs: Marta Sokolowska, PhD; Michael Klein, PhD; and Beatrice Setnik, PhD BPSD Chairs: Larry Ereshefsky, PharmD; David Miller, MD; and Luca Pani, MD BIOMARKERS Chairs: Steven Potkin, MD, and Don Goff, MD COGNITIVE ASSESSMENT IN ALZHEIMER'S DISEASE Chairs: Holly Posner, MD, and Philip Harvey, PhD IDENTIFYING NON-ADHERENCE IN CNS CLINICAL TRIALS Chairs: Thomas Shiovitz, MD, and Earle Bain, MD IMPLEMENTING INNOVATIONS IN CNS CLINICAL TRIALS Chairs: Gary Sachs, MD, and Michael Detke, MD, PhD NEGATIVE SYMPTOMS Chairs: Stephen Marder, MD, and David Daniel, MD SUICIDAL IDEATION AND BEHAVIOR ASSESSMENT Chairs: Larry Alphs, MD, PhD; Phillip Chappell, MD, MBA; Michelle Stewart, PhD

Articles in this issue

Links on this page

Archives of this issue

view archives of Innovations In Clinical Neuroscience - ISCTM Supplement 2015